Amgen (AMGN) Nervous As FDA Paves Way For Novartis AG (NVS) To Copy Drug Neupogen
Sarepta Therapeutics (SRPT) Terminates Chief Science Officer As It Heads Toward Drug Approval
San Diego Biotech Pfenex Inc. (PFNX) Prices IPO At $6 Per Share, Below Downwardly Revised $8 Expectation
Seattle Biotech Immune Design Corporation (IMDZ) Prices IPO At $12 Per Share, The Low End Of The Range
Study Claims Celgene (CELG) Drug Can Drive HIV Out Of Hiding
Boehringer Ingelheim GmbH Withheld Evidence On Blockbuster Blood Thinner
SoCal's Atara Biotherapeutics IPO Delayed By New Test Results
GlaxoSmithKline (GSK) CEO Has Bigger Problem Than China As Sales Drop
Roche (RHHBY) Profit Dented On Diagnostics Writedown
Celsion Corporation (CLSN) Announces Positive Interim Data Update From Its Phase 2 DIGNITY Study In Breast Cancer
Hikma Pharmaceuticals Buys Ben Venue Laboratories's Generic Manufacturing Site
Innapharma: Completion Of Target Enrollment In The Phase 2 EffiKIR Trial
India's Ipca Laboratories Halts Shipments To U.S. From Local Plant After FDA Concerns
Atox Bio Locks In $23 Million
Cubist Pharmaceuticals, Inc. (CBST) Strikes Agreement With Competitor To Delay Generic Cubicin
Amgen (AMGN) Growth In Brazil Picks Up, Eyes Doubling Portfolio By 2020
Gilead Sciences, Inc. (GILD), Medicines Patent Pool Strike Deal: New Opportunity For Indian Drugmakers
Ligand Pharmaceuticals Inc. (LGND) Partner GlaxoSmithKline (GSK) Announces Record Quarterly Promacta™/Revolade™ Revenue Of $92 Million
See All News >
Eli Lilly and Company (LLY) To Cut Up To 100 Indy Jobs, Send Some Work Overseas
Major Restructure At Allergan Inc. (AGN) Amid Valeant Pharmaceuticals International (VRX) Takeover Battle; Allergan Inc. To Cut 1,500 Jobs
Synlogic Secures $29.4 Million Series A Financing Led By Atlas Venture
Candid Advice For Cash-Strapped Startups From A Biotech VC; Success At Lumena Pharmaceuticals
Cambridge-Based Broad Institute To Receive Largest Gift Worldwide: $650 Million
Avalanche Biotechnologies Boosts IPO As 2 More Biotechs Go Public This Week
ViiV Healthcare: HIV Combo Therapy Candidate Fails Phase 3
Agena Biosciences Appoints Peter Dansky As Chief Executive Officer
Cancer Biotech Loxo Oncology Sets Terms For $57 Million IPO
FDA Grants Genentech (RHHBY)’s Avastin Priority Review For Recurrent Platinum-Resistant Ovarian Cancer
Drive to Add FDA Drug Police In India Delayed
SAGE Therapeutics Receives Fast Track Designation For Lead Compound SAGE-547 To Treat Status Epilepticus
Large Allergan Inc. (AGN) Investor Sells Most Of Stake
Can Anything Stop Drug Companies From Fleeing The U.S. Tax System?
Cancer Genetics, Inc. (CGIX) Announces Acquisition Of Gentris Corporation, A Leading Global Pharmacogenomics Company, And Increases Contract Backlog To Over $18 Million
Anacor Pharmaceuticals, Inc. (ANAC) Inks Exclusive Deal With Sandoz, Inc. For Kerydin; Anacor To Receive Upfront $40 Million
Aduro Biotech Receives Breakthrough Therapy Designation From FDA For Innovative Pancreatic Cancer Combination Immunotherapy
Amgen (AMGN) Abruptly Puts 70 People On Leave, Cuts Jobs
See All News >